|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
JP3763997B2
(ja)
|
1999-05-13 |
2006-04-05 |
富士写真フイルム株式会社 |
感熱記録材料
|
|
JP4331823B2
(ja)
|
1999-05-21 |
2009-09-16 |
富士フイルム株式会社 |
ピロロ［１，２−ａ］−１，３，５−トリアジン−４−オン系化合物
|
|
EP1248869A2
(en)
|
2000-01-07 |
2002-10-16 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
JP4070966B2
(ja)
|
2001-06-28 |
2008-04-02 |
株式会社カネボウ化粧品 |
新規ガラクトシルセラミド類縁体及び用途
|
|
WO2003035649A1
(en)
|
2001-10-22 |
2003-05-01 |
Pfizer Japan Inc. |
Imidazopyridine compounds as 5-ht4 receptor modulators
|
|
CN1281606C
(zh)
|
2002-03-01 |
2006-10-25 |
安斯泰来制药有限公司 |
含氮杂环化合物
|
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
|
JP2006502180A
(ja)
|
2002-09-20 |
2006-01-19 |
ファイザー株式会社 |
５−ｈｔ４レセプターモジュレーターとしてのｎ−置換されたピペリジニル−イミダゾピリジン化合物
|
|
US7550470B2
(en)
|
2002-12-11 |
2009-06-23 |
Merck & Co. Inc. |
Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
BRPI0409592A
(pt)
|
2003-04-21 |
2006-05-02 |
Pfizer |
compostos imidazopiridina tendo atividade agonìstica do receptor 5-ht4 e atividade antagonìstica do receptor 5-ht3
|
|
CA2545433A1
(en)
|
2003-11-12 |
2005-05-26 |
Amicus Therapeutics Inc. |
Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease
|
|
GB0329214D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
AU2005212096B2
(en)
|
2004-02-18 |
2010-12-16 |
Msd K.K. |
Nitrogenous fused heteroaromatic ring derivative
|
|
US8318724B2
(en)
|
2004-05-14 |
2012-11-27 |
The Cleveland Clinic Foundation |
Small molecule inhibitors of MRP1 and other multidrug transporters
|
|
BRPI0512330A
(pt)
|
2004-06-21 |
2008-02-26 |
Hoffmann La Roche |
derivados de pirazol-pirimidina
|
|
EP1778685B1
(de)
|
2004-08-02 |
2008-03-26 |
Schwarz Pharma Ag |
Carboxamide des indolizins und seiner aza- und diazaderivate
|
|
DE102004049363A1
(de)
|
2004-10-08 |
2006-04-13 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
CN101107251A
(zh)
|
2005-01-19 |
2008-01-16 |
默克公司 |
用于治疗或预防糖尿病的作为二肽基肽酶-ⅳ抑制剂的双环嘧啶类
|
|
BRPI0607927A2
(pt)
|
2005-02-11 |
2009-10-20 |
Hoffmann La Roche |
derivados de pirazol-pirimidina
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
JPWO2006115168A1
(ja)
|
2005-04-21 |
2008-12-18 |
大日本住友製薬株式会社 |
Ｎ−置換フェニルアセトアミド誘導体およびそれを含有する医薬組成物
|
|
US7906522B2
(en)
|
2005-04-28 |
2011-03-15 |
Kyowa Hakko Kirin Co., Ltd |
2-aminoquinazoline derivatives
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
AR057979A1
(es)
|
2005-10-06 |
2008-01-09 |
Schering Corp |
PIRAZOLPIRIMIDINAS COMO INHIBIDORAS DE PROTEíNA QUINASA. COMPOSICIONES FARMACEUTICAS.
|
|
US8372851B2
(en)
|
2005-10-21 |
2013-02-12 |
Exelixis, Inc. |
Pyrazolo pyrimidines as casein kinase II (CK2) modulators
|
|
CA2629743A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors
|
|
TW200800997A
(en)
*
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2007150064A2
(en)
|
2006-06-23 |
2007-12-27 |
Amicus Therapeutics, Inc. |
METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
WO2008019363A2
(en)
|
2006-08-07 |
2008-02-14 |
Albany Molecular Research, Inc. |
2-alkylbenzoxazole carboxamides as 5ht3 modulators
|
|
CA2670083A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
CA2670044A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic matrix metalloprotease inhibitors
|
|
CA2682016A1
(en)
|
2007-03-28 |
2008-10-02 |
Inovacia Ab |
Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
WO2008157575A1
(en)
|
2007-06-21 |
2008-12-24 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
WO2009060835A1
(ja)
|
2007-11-05 |
2009-05-14 |
Kyoto University |
新規ユビキリン結合性小分子
|
|
EP2217601A1
(en)
|
2007-11-08 |
2010-08-18 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyridazines for use as protein kinase inhibitors
|
|
CN101970440A
(zh)
|
2007-11-28 |
2011-02-09 |
先灵公司 |
作为蛋白激酶抑制剂的2-氟吡唑并[1，5-a]嘧啶类
|
|
WO2009100375A1
(en)
|
2008-02-06 |
2009-08-13 |
Bristol-Myers Squibb Company |
Substituted imidazopyridazines useful as kinase inhibitors
|
|
WO2009119088A1
(ja)
|
2008-03-25 |
2009-10-01 |
武田薬品工業株式会社 |
複素環化合物
|
|
ES2586459T3
(es)
|
2008-05-01 |
2016-10-14 |
Glaxosmithkline Llc |
Quinolinas y análogos relacionados como moduladores de sirtuina
|
|
UY32174A
(es)
|
2008-10-14 |
2010-05-31 |
Astrazeneca Ab |
Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
|
|
EP2348860B1
(en)
*
|
2008-10-31 |
2015-05-27 |
Genentech, Inc. |
Pyrazolopyrimidine jak inhibitor compounds and methods
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
NZ598220A
(en)
|
2009-08-17 |
2014-02-28 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
|
CN110003219A
(zh)
*
|
2010-07-13 |
2019-07-12 |
弗·哈夫曼-拉罗切有限公司 |
作为irak4调节剂的吡唑并[1,5a]嘧啶和噻吩并[3,2b]嘧啶衍生物
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
TW201217312A
(en)
*
|
2010-09-22 |
2012-05-01 |
Gruenenthal Gmbh |
Substituted benzamide compounds
|
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
EP3366688B1
(en)
*
|
2010-12-08 |
2022-02-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Substituted pyrazolopyrimidines as glucocerebrosidase activators
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
US9169260B2
(en)
*
|
2011-03-22 |
2015-10-27 |
Merck Sharp & Dohme Corp. |
Amidopyrazole inhibitors of interleukin receptor-associated kinases
|
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
PH12014500326B1
(en)
|
2011-08-18 |
2018-01-10 |
Nippon Shinyaku Co Ltd |
Heterocyclic derivative and pharmaceutical drug
|
|
CN104039784B
(zh)
|
2011-09-02 |
2017-08-22 |
拜耳知识产权有限责任公司 |
取代的增环嘧啶及其用途
|
|
US8961959B2
(en)
|
2011-10-17 |
2015-02-24 |
The Regents Of The University Of Michigan |
Glucosylceramide synthase inhibitors and therapeutic methods using the same
|
|
JP6073343B2
(ja)
|
2011-10-20 |
2017-02-01 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ |
サーチュイン調節因子としての置換された二環式アザ複素環およびアナログ
|
|
EP2794592A1
(en)
|
2011-12-23 |
2014-10-29 |
Novartis AG |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
|
US9340549B2
(en)
*
|
2012-03-05 |
2016-05-17 |
Amgen Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
WO2013134219A1
(en)
|
2012-03-09 |
2013-09-12 |
Lexicon Pharmaceuticals, Inc. |
Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof
|
|
DK2822555T3
(en)
|
2012-03-09 |
2018-02-05 |
Lexicon Pharmaceuticals Inc |
Inhibition of adapter-associated kinase 1 for the treatment of pain
|
|
JP2015512913A
(ja)
|
2012-03-28 |
2015-04-30 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
グルコセレブロシダーゼ活性剤として有用なサリチル酸誘導体
|
|
JP6231085B2
(ja)
|
2012-05-31 |
2017-11-15 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
アミノキナゾリン誘導体及びピリドピリミジン誘導体
|
|
EP2865671B1
(en)
|
2012-06-22 |
2017-11-01 |
Sumitomo Chemical Company, Ltd |
Fused heterocyclic compound
|
|
WO2014025651A1
(en)
*
|
2012-08-06 |
2014-02-13 |
Amgen Inc. |
Chroman derivatives as trpm8 inhibitors
|
|
US20150216168A1
(en)
|
2012-09-05 |
2015-08-06 |
Bayer Cropscience Ag |
Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
|
|
CA2889919C
(en)
|
2012-11-16 |
2021-08-17 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
HK1215579A1
(zh)
|
2012-11-29 |
2016-09-02 |
Karyopharm Therapeutics, Inc. |
被取代的2，3-二氫苯並呋喃基化合物和其用途
|
|
SI2941432T1
(en)
*
|
2012-12-07 |
2018-07-31 |
Vertex Pharmaceuticals Incorporated |
2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR
|
|
KR20140086002A
(ko)
|
2012-12-28 |
2014-07-08 |
한미약품 주식회사 |
Fms 키나아제 저해 활성을 갖는 피리다진 접합고리 유도체
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
WO2014144455A1
(en)
|
2013-03-15 |
2014-09-18 |
Epizyme, Inc. |
1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
JPWO2015012328A1
(ja)
|
2013-07-24 |
2017-03-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
US20160199372A1
(en)
|
2013-08-20 |
2016-07-14 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
|
EA201690458A1
(ru)
|
2013-08-23 |
2016-07-29 |
Инсайт Корпорейшн |
Фуро- и тиенопиридинкарбоксамиды, используемые в качестве ингибиторов pim-киназы
|
|
AR097543A1
(es)
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
TW201542550A
(zh)
|
2013-09-06 |
2015-11-16 |
Lexicon Pharmaceuticals Inc |
吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
|
|
WO2015073267A1
(en)
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
EP3461812B1
(en)
|
2014-03-27 |
2021-10-13 |
Academisch Medisch Centrum |
N-(5-(biphen-4-ylmethyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
US20180185368A1
(en)
|
2014-11-06 |
2018-07-05 |
Lysosomal Therapeutics Inc. |
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
|
|
US20170333435A1
(en)
|
2014-11-06 |
2017-11-23 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
EP4406616A3
(en)
|
2014-11-06 |
2024-11-06 |
Bial-R&D Investments, S.A. |
Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
|
|
US9802942B2
(en)
|
2015-07-01 |
2017-10-31 |
Northwestern University |
Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
|
|
CN108290855A
(zh)
|
2015-07-01 |
2018-07-17 |
西北大学 |
被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途
|
|
EP3344632A4
(en)
|
2015-09-04 |
2019-03-20 |
Lysosomal Therapeutics Inc. |
Heterocyclic pyrimidine compounds and their use in the treatment of medical disorders
|
|
PT3371190T
(pt)
|
2015-11-06 |
2022-07-08 |
Incyte Corp |
Compostos heterocíclicos como inibidores de pi3k-gamma
|
|
US10479793B2
(en)
|
2015-11-18 |
2019-11-19 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
|
|
JP6936236B2
(ja)
|
2016-02-18 |
2021-09-15 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
治療化合物、組成物及びその方法の使用
|
|
EP3440081A4
(en)
|
2016-04-06 |
2019-09-18 |
Lysosomal Therapeutics Inc. |
PYRROLO [1,2-A] PYRIMIDINYL-CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDER
|
|
CA3020305A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics Inc. |
Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
AU2017246455B2
(en)
|
2016-04-06 |
2021-09-30 |
Bial - R&D Investments, S.A. |
Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
EP3452045A1
(en)
|
2016-05-04 |
2019-03-13 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
KR102530515B1
(ko)
|
2016-05-05 |
2023-05-09 |
비알 - 알&디 인베스트먼츠, 에스.에이. |
치환된 이미다조[1,2-b]피리다진, 치환된 이미다조[1,5-b]피리다진, 관련 화합물, 및 의학적 장애의 치료에서의 그의 용도
|
|
EP3452480A4
(en)
|
2016-05-05 |
2019-11-06 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED PYRROLO [1,2-] TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
WO2017192931A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
JP2021506920A
(ja)
|
2017-12-21 |
2021-02-22 |
リソソーマル・セラピューティクス・インコーポレイテッドＬｙｓｏｓｏｍａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
結晶性の置換シクロヘキシルピラゾロ［１，５−ａ］ピリミジニルカルボキサミド化合物およびその治療的使用
|